Doubleday Amanda R, Sippel Rebecca S
Division of Endocrine Surgery, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Gland Surg. 2020 Feb;9(1):124-135. doi: 10.21037/gs.2019.11.01.
Hyperthyroidism is a condition where the thyroid gland produces and secretes inappropriately high amounts of thyroid hormone which can lead to thyrotoxicosis. The prevalence of hyperthyroidism in the United States is approximately 1.2%. There are many different causes of hyperthyroidism, and the most common causes include Graves' disease (GD), toxic multinodular goiter and toxic adenoma. The diagnosis can be made based on clinical findings and confirmed with biochemical tests and imaging techniques including ultrasound and radioactive iodine uptake scans. This condition impacts many different systems of the body including the integument, musculoskeletal, immune, ophthalmic, reproductive, gastrointestinal and cardiovascular systems. It is important to recognize common cardiovascular manifestations such as hypertension and tachycardia and to treat these patients with beta blockers. Early treatment of cardiovascular manifestations along with treatment of the hyperthyroidism can prevent significant cardiovascular events. Management options for hyperthyroidism include anti-thyroid medications, radioactive iodine, and surgery. Anti-thyroid medications are often used temporarily to treat thyrotoxicosis in preparation for more definitive treatment with radioactive iodine or surgery, but in select cases, patients can remain on antithyroid medications long-term. Radioactive iodine is a successful treatment for hyperthyroidism but should not be used in GD with ophthalmic manifestations. Recent studies have shown an increased concern for the development of secondary cancers as a result of radioactive iodine treatment. In the small percentage of patients who are not successfully treated with radioactive iodine, they can undergo re-treatment or surgery. Surgery includes a total thyroidectomy for GD and toxic multinodular goiters and a thyroid lobectomy for toxic adenomas. Surgery should be considered for those who have a concurrent cancer, in pregnancy, for compressive symptoms and in GD with ophthalmic manifestations. Surgery is cost effective with a high-volume surgeon. Preoperatively, patients should be on anti-thyroid medications to establish a euthyroid state and on beta blockers for any cardiovascular manifestations. Thyroid storm is a rare but life-threatening condition that can occur with thyrotoxicosis that must be treated with a multidisciplinary approach and ultimately, definitive treatment of the hyperthyroidism.
甲状腺功能亢进症是一种甲状腺产生并分泌过量甲状腺激素,进而可能导致甲状腺毒症的病症。在美国,甲状腺功能亢进症的患病率约为1.2%。甲状腺功能亢进症有多种不同病因,最常见的病因包括格雷夫斯病(GD)、毒性多结节性甲状腺肿和毒性腺瘤。可根据临床表现做出诊断,并通过生化检查以及包括超声和放射性碘摄取扫描在内的成像技术加以确诊。这种病症会影响身体的许多不同系统,包括皮肤、肌肉骨骼、免疫、眼科、生殖、胃肠道和心血管系统。认识到高血压和心动过速等常见心血管表现并使用β受体阻滞剂治疗这些患者很重要。早期治疗心血管表现以及甲状腺功能亢进症可预防重大心血管事件。甲状腺功能亢进症的治疗选择包括抗甲状腺药物、放射性碘和手术。抗甲状腺药物通常用于临时治疗甲状腺毒症,为采用放射性碘或手术进行更明确的治疗做准备,但在某些情况下,患者可长期服用抗甲状腺药物。放射性碘是治疗甲状腺功能亢进症的一种有效方法,但患有眼部表现的GD患者不应使用。最近的研究表明,人们越来越担心放射性碘治疗会导致继发性癌症。在未成功接受放射性碘治疗的小部分患者中,他们可接受再次治疗或手术。手术包括对GD和毒性多结节性甲状腺肿进行全甲状腺切除术,对毒性腺瘤进行甲状腺叶切除术。对于患有并发癌症、处于妊娠期、有压迫症状以及患有眼部表现的GD患者,应考虑手术治疗。由经验丰富的外科医生进行手术具有成本效益。术前,患者应服用抗甲状腺药物以建立甲状腺功能正常状态,并服用β受体阻滞剂以应对任何心血管表现。甲状腺危象是一种罕见但危及生命的病症,可发生于甲状腺毒症,必须采用多学科方法进行治疗,最终对甲状腺功能亢进症进行明确治疗。